These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 25675191)
21. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group. Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969 [TBL] [Abstract][Full Text] [Related]
23. Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma. Kim YT; Cho NH; Park SW; Kim JW Gynecol Oncol; 1998 Oct; 71(1):38-45. PubMed ID: 9784316 [TBL] [Abstract][Full Text] [Related]
24. p16, p14, p53, and cyclin D1 expression and HPV analysis in small cell carcinomas of the uterine cervix. Horn LC; Lindner K; Szepankiewicz G; Edelmann J; Hentschel B; Tannapfel A; Bilek K; Liebert UG; Richter CE; Einenkel J; Leo C Int J Gynecol Pathol; 2006 Apr; 25(2):182-6. PubMed ID: 16633070 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers. Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563 [TBL] [Abstract][Full Text] [Related]
26. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization. Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678 [TBL] [Abstract][Full Text] [Related]
27. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations. Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma. Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420 [TBL] [Abstract][Full Text] [Related]
29. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
30. Abnormal expression of sex steroid receptors and cell cycle-related molecules in adenocarcinoma in situ of the uterine cervix. Lu X; Shiozawa T; Nakayama K; Toki T; Nikaido T; Fujii S Int J Gynecol Pathol; 1999 Apr; 18(2):109-14. PubMed ID: 10202666 [TBL] [Abstract][Full Text] [Related]
31. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Lu DW; El-Mofty SK; Wang HL Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066 [TBL] [Abstract][Full Text] [Related]
32. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas. Liu X; Yang WT; Zheng PS Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645 [TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of adenocarcinoma of the cervix. Parker MF; Arroyo GF; Geradts J; Sabichi AL; Park RC; Taylor RR; Birrer MJ Gynecol Oncol; 1997 Feb; 64(2):242-51. PubMed ID: 9038270 [TBL] [Abstract][Full Text] [Related]
35. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386 [TBL] [Abstract][Full Text] [Related]
37. Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma. Altavilla G; Staffieri A; Busatto G; Canesso A; Giacomelli L; Marioni G Acta Otolaryngol; 2009 Nov; 129(11):1242-9. PubMed ID: 19863319 [TBL] [Abstract][Full Text] [Related]
38. [p16 and PR immunoreactivity and human papillomavirus infection in endocervical adenocarcinoma]. Liu X; Li Q; Chen W; Li L; Shen G; Zhang X Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):263-7. PubMed ID: 24989911 [TBL] [Abstract][Full Text] [Related]
39. Immunophenotype and human papillomavirus status of serous adenocarcinoma of the uterine cervix. Togami S; Sasajima Y; Kasamatsu T; Oda-Otomo R; Okada S; Ishikawa M; Ikeda S; Kato T; Tsuda H Pathol Oncol Res; 2015 Apr; 21(2):487-94. PubMed ID: 25370301 [TBL] [Abstract][Full Text] [Related]
40. [Role of HPV DNA detection and p16(INK4A) protein expression in diagnosis of endocervical adenocarcinoma]. Meng ZL; Guo LN; Luo YF; Cao JL; Wan JW; Liu TH Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):810-3. PubMed ID: 18346352 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]